* Complete clearance was defined as the percentage of patients with 100% clearance of all AKs in the field, whether present or emergent during treatment, assessed at Day 57 (P<0.001). Partial clearance as defined as the percentage of patients with ≥75% clearance of all AKs in the field, whether present or emergent during treatment, assessed at Day 57 (P<0.001).
† In studies with Picato®, results were measured at Week 8 (Day 57).
These images represent a range of skin reactions, from mild to severe, experienced by patients treated in 2 actinic keratosis clinical trials on the face and scalp. Individual results may vary. Consult your healthcare provider if symptoms persist or become more severe.
The most common side effects with Picato® gel on the face and scalp (≥2%) include skin reactions in the treatment area (94%), pain at the treatment area (15%), itching at the treatment area (8%), infection at the treatment area (3%), swelling around your eyelids (3%), and headache (2%).
These images represent a range of skin reactions, from mild to severe, experienced by patients treated in 2 actinic keratosis clinical trials on the body, arms, and legs. Individual results may vary. Consult your healthcare provider if symptoms persist or become more severe.
The most common side effects with Picato® gel on the body, arms, and legs (≥2%) include skin reactions in the treatment area (92%), itching at the treatment area (8%), skin irritation at the treatment area (4%), nose and throat irritation (2%), and pain at the treatment area (2%).
Most patients experienced mild to moderate skin reactions in clinical studies. However, some patients experienced severe skin reactions, including redness, flaking or scaling, crusting, swelling, blistering, pus, ulcers, or breakdown of skin.
If you feel that you are suffering from a severe skin reaction, talk to your healthcare professional.